The House Dec. 11 voted 320-71 to pass legislation (H.R. 5378) that would delay a Jan. 19 payment reduction to Medicaid disproportionate share hospitals for two years, but permanently reduce Medicare payments for drug administration services in off-campus hospital outpatient departments. Among other provisions, the bill codifies the Hospital Price Transparency Rule but makes key changes, including no longer allowing the use of price estimator tools to meet the shoppable services requirement and increasing civil monetary penalties for noncompliance.

“While the AHA appreciates inclusion of a two-year delay on DSH cuts, we have been very clear regarding the harm that would be done to our nation’s hospitals if so-called site-neutral cuts to Medicare were adopted,” AHA President and CEO Rick Pollack said in a statement shared yesterday with reporters and House members. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
AHA March 26 submitted comments on a discussion draft of the SUSTAIN 340B Act, legislation proposed in the Senate to clarify Congress’ intent in creating the…
Headline
President Biden March 24 signed legislation funding the rest of the federal government through Sept. 30, including Department of Health and Human Services…
Headline
The House and Senate Appropriations committees March 20 released the Further Consolidated Appropriations Act of 2024, legislation that would fund all remaining…
Headline
The House Energy and Commerce Committee March 20 unanimously passed AHA-supported legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care…
Headline
A March 14 editorial in the Washington Post calling for Congress to enact so-called site-neutral policies is “deeply flawed and incredibly out of touch with…